Europe — EMA
Fibclot (Human Fibrinogen)
Human Fibrinogen (Fibclot) is a clotting factor used to manage bleeding disorders. This intravenous medication supports blood coagulation, crucial for surgical
Request sourcing
What is Human Fibrinogen?
Human Fibrinogen (Fibclot) is a clotting factor used to manage bleeding disorders. This intravenous medication supports blood coagulation, crucial for surgical or trauma-related bleeding. Learn more about Fibclot's role in hemostasis.
What is Human Fibrinogen used for?
Human Fibrinogen, marketed as Fibclot, is primarily used to control bleeding in conditions where clotting factors are deficient. It is often administered intravenously to support hemostasis during surgical procedures or in cases of trauma. Fibclot is designed to help manage bleeding disorders by promoting blood clot formation.
What are the side effects of Human Fibrinogen?
When administered, Fibclot works to enhance the body's natural clotting process. This can help reduce bleeding time and support wound healing. Common effects may include localized reactions at the injection site, though individual responses can vary.
What precautions apply to Human Fibrinogen?
Fibclot should be handled with care, ensuring proper storage and administration protocols are followed. Patients with known allergies to fibrinogen or its components should avoid its use. Always consult healthcare providers for personalized advice.
What does Human Fibrinogen interact with?
Fibclot may interact with other medications that affect blood clotting. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions.



